Select your country

Africa
Asia
Europe
Latin America
North America
Oceania

Q1 2018 Press Conference, and Analyst Call

Our Q1/2018 results will be published on May 15, 2018, at 7 a.m. CEST. Our press conference will take place at 9:30 AM CET, and the analyst call at 2 p.m. CEST

15 May 2018

From 07:00 to 15:00

We achieve targets for 2017 – dividend to increase

  • Healthcare and Life Science drive sales growth (+2.0%)
  • EBITDA pre (–1.7%) burdened by currency headwinds
  • Organic sales growth in all regions
  • Progress made in reducing net financial debt
  • Dividend proposal € 1.25 (+€ 0.05)

We are staying the course

“2017 was a good year for our company. We performed well in a challenging environment and met all ourtargets for  the year. We are staying the course and will continue to purposefully implement our innovation-driven growth strategies for Healthcare, Life Science and Performance Materials. In addition, we are resolutely working to quickly lower our acquisition-related debt-to-equity ratio.”
(Stefan Oschmann, CEO and Chairman of the Executive Board)

Related News

View All News

Press Releases

Merck KGaA, Darmstadt, Germany, Reports a Solid Start to 2018

Merck KGaA, Darmstadt, Germany today reported a decline in sales in the first quarter of 2018 despite organic growth. This was due to negative foreign exchange effects.

2018/05/15

Markus Talanow

Financial Communications

Constantin Fest

Head of Investor Relations

Redirect

You have accessed emdgroup.com, but for users from your part of the world, we originally designed the following web presence merckgroup.com

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement